Shreffler:Notebook/Alex Daily/2010/06/02

{| width="800"
 * style="background-color: #EEE"|[[Image:owwnotebook_icon.png|128px]] Project name
 * style="background-color: #F2F2F2" align="center"|  |Main project page
 * style="background-color: #F2F2F2" align="center"|  |Main project page


 * colspan="2"|
 * colspan="2"|

R03 - CaFree (Experiment #5)

 * Obtained buffy coat from Tuesday (6/1) drawing.
 * Going back to 1X DHR (used 8X in past few experiments)
 * 8X added 96 uL 5mM DHR solution to 6 mL total blood+rpmi, now back to 12uL
 * Can eliminate DMSO rows.


 * Experiment row layout:
 * RPMI
 * fMLP starting at 0.5 uM; threefold dilutions
 * Anti-IgE starting at 10 ug/mL; threefold dilutions
 * Anti-IgE row, now in Ca free conditions (EDTA 5 mM in RPMI, final conc. 2.5 mM)


 * Abs panel:
 * CD63 PE (Lot: 64074)
 * CD123 PE-Cy5 (Lot: 65847)
 * CD203c PE-Cy7 (Lot: 02, Exp: 2011-01-22)
 * HLA DR APC (Lot: 65678)

Tried a couple things:
 * Used cold PBS after stim step to halt degranulation
 * Drew higher blood volume into pipettes to compensate for viscosity (blood retention on sides of pipette tips).

Carbo (004 ADB)

 * Past experiments used IgE at 10 ug/mL (30 uL from aliquot into 270 uL RPMI), which is supraoptimal. Changed IgE concentration to 1 ug/mL.
 * Also began using IL-3 in fMLP/IgE samples (past experiments did not).


 * }